Citation Impact
Citing Papers
Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance
2018 Standout
A randomised phase II/III trial of 3-weekly cisplatin-based sequential transarterial chemoembolisation vs embolisation alone for hepatocellular carcinoma
2013
Cochrane Database of Systematic Reviews
2003 Standout
Trends in Utilization of Transarterial Treatments for Hepatocellular Carcinoma: Results of a Survey by the Italian Society of Interventional Radiology
2013
Orantinib versus placebo combined with transcatheter arterial chemoembolisation in patients with unresectable hepatocellular carcinoma (ORIENTAL): a randomised, double-blind, placebo-controlled, multicentre, phase 3 study
2017
Survival of patients with hepatocellular carcinoma treated by transarterial chemoembolisation (TACE) using Drug Eluting Beads. Implications for clinical practice and trial design
2012
Molecular imaging in drug development
2008 Standout
Acute Eosinophilic and Neutrophilic Pneumonia following Transarterial Chemoembolization with Drug-Eluting Beads Loaded with Doxorubicin for Hepatocellular Carcinoma: A Case Report
2014
American Gastroenterological Association Institute Guideline on the Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
2014
International myeloma working group consensus statement and guidelines regarding the current role of imaging techniques in the diagnosis and monitoring of multiple Myeloma
2009
TACE Treatment in Patients with Sorafenib-treated Unresectable Hepatocellular Carcinoma in Clinical Practice: Final Analysis of GIDEON
2016
Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2014 Standout
Natural history and prognostic indicators of survival in cirrhosis: A systematic review of 118 studies
2005 Standout
Hepatocellular carcinoma
2016 Standout
Hepatocellular carcinoma
2018 Standout
Updated use of TACE for hepatocellular carcinoma treatment: How and when to use it based on clinical evidence
2018
Drug-eluting beads versus conventional chemoembolization for the treatment of unresectable hepatocellular carcinoma: A meta-analysis
2016
Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization
2014
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
2005 Standout
Performance of imaging modalities in diagnosis of liver metastases from colorectal cancer: A systematic review and meta‐analysis
2009
Response rate and clinical outcome of HCC after first and repeated cTACE performed “on demand”
2012
Detection of residual tumor after radiofrequency ablation of liver metastasis with dual-modality PET/CT: initial results
2005
Large (≥5.0-cm) HCCs: Multipolar RF Ablation with Three Internally Cooled Bipolar Electrodes—Initial Experience in 26 Patients
2008
The global health burden of infection‐associated cancers in the year 2002
2006 Standout
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
2021
Long-term increase in uterine blood flow is achieved by local overexpression of VEGF-A165 in the uterine arteries of pregnant sheep
2011
Hepatocellular carcinoma
2012 Standout
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
2004 Standout
Hepatocellular carcinoma
2021 Standout
A global view of hepatocellular carcinoma: trends, risk, prevention and management
2019 Standout
BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update
2021 Standout
American Gastroenterological Association Institute Technical Review on Prevention and Treatment of Hepatitis B Virus Reactivation During Immunosuppressive Drug Therapy
2014
Diagnosis and management of cricopharyngeal achalasia and other upper esophageal sphincter opening disorders
2000
Chemoembolization With Doxorubicin-Eluting Beads for Unresectable Hepatocellular Carcinoma: Five-Year Survival Analysis
2012
Colorectal cancer
2013 Standout
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
2016
Prevention of VTE in Nonsurgical Patients
2012 Standout
Vascular disorders of the liver # †
2008 Standout
AGA technical review on nonalcoholic fatty liver disease
2002
Virus associated malignancies: The role of viral hepatitis in hepatocellular carcinoma
2014 StandoutNobel
Comparative 13-year meta-analysis of the sensitivity and positive predictive value of ultrasound, CT, and MRI for detecting hepatocellular carcinoma
2015
Transarterial radioembolizationvschemoembolization for hepatocarcinoma patients: A systematic review and meta-analysis
2016
Second Cancers Among 40 576 Testicular Cancer Patients: Focus on Long-term Survivors
2005 Standout
Evolving strategies for the management of intermediate-stage hepatocellular carcinoma: Available evidence and expert opinion on the use of transarterial chemoembolization
2010
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018
Liver cancer: Approaching a personalized care
2015
Second Malignancies following Pure Seminoma
2000
Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease
2005 Standout
Sorafenib or placebo plus TACE with doxorubicin-eluting beads for intermediate stage HCC: The SPACE trial
2016
Liver and biliary damages following transarterial chemoembolization of hepatocellular carcinoma: comparison between drug-eluting beads and lipiodol emulsion
2016
Remodelling the extracellular matrix in development and disease
2014 Standout
Transarterial therapies for hepatocellular carcinoma
2011
A novel panel of blood markers to assess the degree of liver fibrosis†
2005
Prevention of Venous Thromboembolism
2004 Standout
Loco‐regional treatment of hepatocellular carcinoma†
2010
Management of HCC
2012
Severity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinoma
2011
HIV‐associated lymphoma in Africa: An autopsy study in Ĉote D'ivoire
1994
Modified RECIST to assess tumor response after transarterial chemoembolization of hepatocellular carcinoma: CT–pathologic correlation in 178 liver explants
2013
The treatment of intermediate stage tumours beyond TACE: From surgery to systemic therapy
2017
Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma
2014
The ART of decision making: Retreatment with transarterial chemoembolization in patients with hepatocellular carcinoma
2013
FIB-4
2007 Standout
Prevention of Venous Thromboembolism
2008 Standout
Treatment of intermediate-stage hepatocellular carcinoma
2014
Local-Regional Treatment of Hepatocellular Carcinoma
2011
On the mechanisms of biocompatibility
2008 Standout
Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial
2017
Congenital and Acquired Anomalies of the Portal Venous System
2002
Randomised controlled trial of doxorubicin-eluting beads vs conventional chemoembolisation for hepatocellular carcinoma
2014
Prospective Randomized Comparison of Chemoembolization with Doxorubicin-Eluting Beads and Bland Embolization with BeadBlock for Hepatocellular Carcinoma
2009
Transarterial embolization with or without chemotherapy for advanced hepatocellular carcinoma: a systematic review
2014
Transarterial chemoembolization: Evidences from the literature and applications in hepatocellular carcinoma patients
2015
Heterogeneity of intermediate-stage HCC necessitates personalized management including surgery
2014
Transarterial chemoembolization in very early and early-stage hepatocellular carcinoma patients excluded from curative treatment: A prospective cohort study
2011
Hepatocellular Carcinoma
2011 Standout
Renal cell carcinoma
2017 Standout
Predictive Factors of Downstaging of Hepatocellular Carcinoma Beyond the Milan Criteria Treated with Intra-arterial Therapies
2012
Treatment of Liver Tumors with Lipiodol TACE: Technical Recommendations from Experts Opinion
2015
Hepatocellular carcinoma
2022 Standout
Hepatocellular carcinoma: a global view
2010
The invasive and saprophytic syndromes due toAspergillusspp.
2005
Targeted Therapies for Hepatocellular Carcinoma
2011
AASLD Practice Guidance on the clinical assessment and management of nonalcoholic fatty liver disease
2023 Standout
Local and Regional Therapies for Hepatocellular Carcinoma
2020
Ionizable Lipid Nanoparticles for In Vivo mRNA Delivery to the Placenta during Pregnancy
2023 StandoutNobel
Hepatocellular Carcinoma
2019 Standout
Imaging modalities for the non-invasive diagnosis of endometriosis
2016
Transarterial embolization as neo‐adjuvant therapy pretransplantation in patients with hepatocellular carcinoma
2013
AASLD guidelines for the treatment of hepatocellular carcinoma
2017 Standout
EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
2017 Standout
A randomized placebo‐controlled trial of prophylactic dexamethasone for transcatheter arterial chemoembolization
2017
Deep vein thrombosis associated with central venous catheters – a review
2005
Position paper of the Italian Association for the Study of the Liver (AISF): The multidisciplinary clinical approach to hepatocellular carcinoma
2013
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
2020
Transarterial Chemoembolization and Radioembolization
2014
Randomized Trial of Hepatic Artery Embolization for Hepatocellular Carcinoma Using Doxorubicin-Eluting Microspheres Compared With Embolization With Microspheres Alone
2016
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
2018 Standout
Improvement of prognostic power of the Child–Pugh classification of liver cirrhosis by hyaluronan
2003
Endometriosis
2020 Standout
Lipiodol transarterial chemoembolization for hepatocellular carcinoma: A systematic review of efficacy and safety data
2016
Treatment of Aspergillosis: Clinical Practice Guidelines of the Infectious Diseases Society of America
2008 Standout
EASL Clinical Practice Guidelines: Management of hepatocellular carcinoma
2018 Standout
Global cancer statistics, 2012
2015 Standout
Multiple Myeloma
2011 Standout
Hidden Killers: Human Fungal Infections
2012 Standout
Imaging Techniques for the Diagnosis of Hepatocellular Carcinoma
2015
Works of P. Chevallier being referenced
Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V Study
2009
Can low-dose computed tomographic scan of the spine replace conventional radiography? An evaluation based on imaging myelomas, bone metastases, and fractures from osteoporosis
2007
Hepatic multi-nodular focal fatty metamorphosis in acquired porphyria cutanea tarda
1998
Modification of Arterial and Portal Hemodynamics after Injection of Iodized Oils and Different Emulsions of Iodized Oils in the Hepatic Artery: An Experimental Study
1998
Radio-frequency tissue ablation of the liver: in vivo and ex vivo experiments with four different systems
2003
Obstetrical prognosis and pregnancy outcome following pelvic arterial embolisation for post-partum hemorrhage
2009
Pseudomembranous aspergillus bronchitis in a double-lung transplanted patient: unusual radiographic and CT features
2000
Percutaneous Gastrostomy with Fluoroscopic Guidance: Single-Center Experience in 500 Consecutive Cancer Patients
1999
Detection of portal venous gas on sonography, but not on CT
2001
Gadodiamide and Gadopentetate Dimeglumine in MRI versus Spiral CT in the Diagnosis of Liver Lesions
2002
Agenesis of the horizontal segment of the left portal vein demonstrated by magnetic resonance imaging including phase-contrast magnetic resonance venography
2000
Non invasive prediction of severe fibrosis in patients with alcoholic liver disease.
2000
The Value of Pelvic MRI in the Diagnosis of Posterior Cul-De-Sac Obliteration in Cases of Deep Pelvic Endometriosis
2012
Quadruple-Phase MDCT of the Liver in Patients with Suspected Hepatocellular Carcinoma: Effect of Contrast Material Flow Rate
2006
[Cancer of the testis after Hodgkin's disease. Apropos of 2 cases].
1992
Hypercalcaemia associated with resorbable haemostatic compresses.
1982